OINCX
Price
$24.48
Change
+$0.08 (+0.33%)
Updated
Jul 25 closing price
Net Assets
43.97B
VVIAX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

OINCX vs VVIAX

Header iconOINCX vs VVIAX Comparison
Open Charts OINCX vs VVIAXBanner chart's image
JPMorgan Equity Income C
Price$24.48
Change+$0.08 (+0.33%)
VolumeN/A
Net Assets43.97B
Vanguard Value Index Adm
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
OINCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OINCX vs. VVIAX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OINCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 195B vs. OINCX (44B). VVIAX pays higher dividends than OINCX: VVIAX (2.18) vs OINCX (1.05). OINCX was incepted earlier than VVIAX: OINCX (28 years) vs VVIAX (25 years). OINCX (1.45) is less costly to investors than VVIAX (0.05). OINCX is a more actively managed with annual turnover of: 20.00 vs. VVIAX (9.00). OINCX has a lower initial minimum investment than VVIAX: OINCX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 9.30 vs. OINCX (4.76). VVIAX return over 5 years is better than : 74.15 vs. OINCX (54.60).
OINCXVVIAXOINCX / VVIAX
Total Expense Ratio1.450.052,900%
Annual Report Gross Expense Ratio1.450.052,900%
Fund Existence28 years25 years-
Gain YTD7.5126.274120%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets44B195B23%
Annual Yield % from dividends1.052.1848%
Returns for 1 year4.769.3051%
Returns for 3 years19.3133.7757%
Returns for 5 years54.6074.1574%
Returns for 10 years96.46115.3784%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVO4.260.21
+5.19%
Evotec SE
MAPS0.970.02
+2.12%
WM Technology
EG336.860.99
+0.29%
Everest Group Ltd
ARTL13.73-0.03
-0.22%
Artelo Biosciences Inc
BCAX11.75-0.18
-1.51%
Bicara Therapeutics Inc.